BioNTech updates
$BioNTech(BNTX.US$ usd 126.58 2023 sales expected to be lower due to tapering demand for Covid-19 vaccine (ref fiercepharma.com). several lawsuits: This year, Arbutus Biopharma to file patent lawsuit against Pfizer & BioNTech over Covid vaccines (ref. Reuter). In 2022, Moderna and Alnylam respectively sued Pfizer/BioNTech for patent infringement. Any good news? Jan 2023 BioNTech partnered with UK Government to provide patients with personalised mRNA cancer immunotherapies by 2030 (ref. investors.biontech.de).
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment